• About
  • Subscribe
  • Advertise
  • Contact
Thursday, July 23, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

Rodenstock announces ‘new era’ in photochromic lens technology

by Rob Mitchell
April 20, 2026
in News, Ophthalmic insights, Ophthalmic lenses
Reading Time: 3 mins read
A A
The range includes ColorMatic Dark, which have the deepest darkening optimised for warmer climates. Image: Rodenstock.

The range includes ColorMatic Dark, which have the deepest darkening optimised for warmer climates. Image: Rodenstock.

Share on FacebookShare on Twitter

Biometric ophthalmic lens manufacturer Rodenstock has announced what it calls a “new era” in photochromic lens technology: ColorMatic X.

In a media release, the company said the lens was its fastest and clearest photochromic performance yet.

The range included ColorMatic Dark, which had the deepest darkening optimised for warmer climates up to 35°C and which activated behind the car windscreen.

The company said the Rodenstock laboratory in Germany had over 35 years of photochromic expertise, and that ColorMatic stood for German engineering excellence.

Rodenstock had a clear focus on innovation and was constantly improving photochromic speed and stability.

The pioneering work in this area was reflected in over 45 patents, it said.

ColorMatic is an innovative and high-performance technology for photochromic lenses offering protection against harmful UV light, artificial blue light and glare.

Engineered for fast reaction, high durability and all-day comfort, the UV light sensitive lenses are elevated to the next level, Rodenstock said.

ColorMatic lenses contain visible light-sensitive molecules in the lens material. When exposed to UV light, these molecules change structure and darken the lens. Indoors, without UV, they return to their clear state. This constant reaction means the lenses adapt seamlessly to changing light.

Up to 30% of adults today struggle with light sensitivity, and the demand for solutions is growing fast.

But not all photochromic lenses were built equally, Rodenstock said.

The differences are measurable: reaction speed to tint and fade back to clear, durability, and optical clarity, each defined by the photochromic technology.

With its latest advances in photochromic materials and engineering, ColorMatic lenses are now designed to bring photochromic lenses to the highest performance level offering relaxed vision especially for light-sensitive spectacle wearers.

With ColorMatic X, Rodenstock said it was presenting its fastest photochromic lens yet, in which fade back had been fast-forwarded.

Indoors, the lens can thus change from the darkened state to the clear state at an accelerated rate – 56% quicker than before1).

Fade-back speed is an important factor for photochromic lenses as the faster the lens becomes clear, the more seamless the experience for the wearer.

When indoors, even a small difference in clarity can have significant impact on the wearing comfort.

This was why Rodenstock said it had strived to engineer photochromic lenses, reaching an impressive 93% clarity. The result: spectacle wearers won’t even notice that they are wearing photochromic lenses indoors.

Another advantage is that the lenses darken deeply to 88% outdoors, equating to category 3 sunglass protection, that helps filter more blue- violet light2), and blocks 100% of UVA and UVB.

Optimised for moderate climates (23°C), it is the ideal choice for those seeking reliable light protection throughout the day and all around the year. ColorMatic X is now available in all indices.

Those keen to know more can find further at https://www.colormatic-lenses.com/

 References:

1) vs ColorMatic® 3

2) ColorMatic® X filters up to 55% more blue-violet light indoors and up to 200% outdoors vs a clear lens

Related Posts

The spring daylight saving transition when clocks move forward by one hour, was associated with a 20–30% higher risk of developing some vision-threatening retinal vascular diseases. Image: Vladimir/stock.adobe.com.

Daylight saving linked to retinal disease risk, US study finds

by Helen Carter
July 22, 2026

The switch to daylight saving may increase the risk of developing serious retinal disease, according to a large US study....

ZEISS MCI Patents

Webinar to focus on use of OCT in clinical optometry

by Rob Mitchell
July 22, 2026

ZEISS is inviting eyecare professionals to join an online, hosted webinar session highlighting OCT in Clinical Optometry. CPD will be available...

Rodenstock Australia GM Tim McCann (from left), See Side Optical co-owners Linda Simpson and Sonya Broadhead, and ODA CEO April Petrusma. Image: ODA.

ODA profile: Being you is your superpower

by Sonya Broadhead
July 21, 2026

MEMBER PROFILE Name: Sonya Broadhead Position: Director/optical dispenser/co-owner Location: See Side Optical, Thirroul, NSW Years in industry: More than 28...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Products
    • Ophthalmic Treatments
      • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited